LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
01 1LGM Pharma
02 2Cohance Lifesciences
03 3Dr. Reddy's Laboratories
04 1Jai Radhe Sales
05 1Chynops Pharma
06 1HRV Global Life Sciences
07 1Shandong Loncom Pharmaceutical
08 1SCI Pharmtech
09 1Apotex Pharmachem
10 1Aspire Lifesciences Pvt Ltd
11 1Aurobindo Pharma Limited
12 1Cadila Pharmaceuticals
13 1Glenmark Life Sciences
14 1Glenmark Pharmaceuticals
15 1Guangzhou Tosun Pharmaceutical
16 2Hetero Drugs
17 2MSN Laboratories
18 1Macleods Pharmaceuticals Limited
19 1Olon S.p.A
20 1R L Fine Chem
21 1Sharon Bio-Medicine Limited
22 1Sicor Societa Italiana Corticosteroidi Srl
23 1Smilax Laboratories Limited
24 1Sun Pharmaceutical Industries Limited
25 1Syn-Tech Chem. & Pharm
26 1TATEYAMA KASEI CO LTD
27 1Teva API
28 1Tivan Sciences
29 1Unichem Laboratories Limited
30 1Viatris
31 1Zhejiang Jiuzhou Pharmaceutical
32 1Zydus Lifesciences
33 1Blank
01 1Canada
02 3China
03 25India
04 1Israel
05 2Italy
06 1Japan
07 2Taiwan
08 2U.S.A
09 1Blank
01 15Active
02 2Inactive
03 21Blank
01 10Valid
02 28Blank
01 1229MF10113
02 1229MF10128
03 1229MF10133
04 1229MF10156
05 1303MF10088
06 1306MF10005
07 32Blank
01 1WC-0023
02 1WC-0035A3
03 1WC-0035a
04 1WC-0041
05 1WC-0062
06 1WC-0074
07 1WC-0118
08 1WC-0153
09 1WC-0168
10 1WC-0195
11 1WC-0281A3
12 1WC-0281new2
13 1WC-0390
14 25Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-12-27
Pay. Date : 2019-12-03
DMF Number : 29211
Submission : 2015-03-26
Status : Active
Type : II
Certificate Number : CEP 2015-150 - Rev 01
Issue Date : 2024-07-09
Type : Chemical
Substance Number : 2640
Status : Valid
Date of Issue : 2022-08-25
Valid Till : 2025-07-02
Written Confirmation Number : WC-0195
Address of the Firm :
NDC Package Code : 76072-1011
Start Marketing Date : 2017-06-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : CN, CA |
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18440
Submission : 2005-06-22
Status : Active
Type : II
Date of Issue : 2022-07-28
Valid Till : 2025-11-30
Written Confirmation Number : WC-0390
Address of the Firm :
NDC Package Code : 55111-071
Start Marketing Date : 2005-06-22
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Chynops Pharma is an ideal sourcing partner for high-quality APIs, advanced intermediates, speciality chemicals & excipients.
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-12-12
Pay. Date : 2020-11-09
DMF Number : 32363
Submission : 2018-06-28
Status : Active
Type : II
Certificate Number : CEP 2017-029 - Rev 03
Issue Date : 2023-10-11
Type : Chemical
Substance Number : 2640
Status : Valid
NDC Package Code : 68108-0772
Start Marketing Date : 2018-08-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Certificate Number : CEP 2019-212 - Rev 02
Issue Date : 2024-07-10
Type : Chemical
Substance Number : 2640
Status : Valid
NDC Package Code : 76072-1011
Start Marketing Date : 2017-06-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : CN, CA |
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Date of Issue : 2022-06-15
Valid Till : 2025-06-25
Written Confirmation Number : WC-0035A3
Address of the Firm :
NDC Package Code : 55111-071
Start Marketing Date : 2005-06-22
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
We have 32 companies offering Atomoxetine
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?